The Global Absorbable Hemostats Market is driven by increasing number of surgeries
Absorbable hemostats are special medical devices or agents used to control bleeding during surgical procedures by accelerating the clotting process of blood. Made from natural materials such as cellulose, collagen, and oxidized regenerated cellulose, absorbable hemostats function by absorbing body fluids and promoting a localized concentration of platelets and coagulation factors required for effective clot formation. They help in decreasing blood loss during complex surgeries and improve visibility of the surgical area, thereby providing surgeons more control during procedures.
The absorbable hemostats market is estimated to be valued at USD 2.87 Bn in 2024 and is expected to reach USD 4.455 Bn by 2031, growing at a compound annual growth rate (CAGR) of 6.5% from 2024 to 2031.
The key driver boosting the Absorbable Hemostats Market is increasing number of surgical procedures worldwide. As per estimates, over 100 million inpatient surgeries and 200 million outpatient surgeries are performed annually in the United States. Additionally, rising prevalence of lifestyle diseases such as diabetes and obesity have contributed to greater number of complex bariatric and cancer surgeries requiring better blood loss management capabilities offered by absorbable hemostats. The enhanced effectiveness of absorbable hemostats in reducing bleeding compared to manual compression techniques has further augmented their adoption across hospitals globally.
Get More Insights On- Absorbable Hemostats Market
Get This Report in Japanese Language: 吸収性止血剤市場
Get This Report in Korean Language: 흡수성 지혈제 시장
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian